|
1 Gubler MC. Podocyte differentiation and hereditary proteinuria/nephrotic syndromes. J Am Soc Nephrol, 2003, 14(Suppl 1): S22–S26.
|
|
2 Kestila M, Lenkkeri U, Mannikko M, et al. Positionally cloned gene for a novel glomerular protein–nephrin——is mutated in congenital nephrotic syndrome. Mol Cell, 1998, 1(4): 575–582.
|
|
3 Yu Z, Ding J, Huang J, et al. Mutations in NPHS2 in sporadic steroid–resistant nephrotic syndrome in Chinese children. Nephrol Dial Transplant, 2005, 20(5): 902–908.
|
|
4 Mao J, Zhang Y, Du L, et al. NPHS1 and NPHS2 gene mutations in Chinese children with sporadic nephrotic syndrome. Pediatr Res, 2007, 61(1): 117–122.
|
|
5 Koop K, Eikmans M, Baelde HJ, et al. Expression of podocyte–associated molecules in acquired human kidney diseases. J Am Soc Nephrol, 2003, 14(8): 2063–2071.
|
|
6 Zhang Y, Wei M, Wang Q, et al. Study on the establishment of the model of minimal change nephropathy with adriamycin in rats. J Beijing Univ Tradit Chin Med, 2002, 25(2): 16–18.[张悦，魏民，王谦，等. 阿霉素复制大鼠微小病变肾病模型的研究．北京中医药大学学报，2002, 25(2): 16–18.]
|
|
7 Yu L, Wen J, Zhao D, et al. Expression of nephrin in glomerulosclerosis rats model induced by adriamycin. J Appl Clin Pediatr, 2007, 22(17): 1299–1301.[于力，温捷，赵丹，等. nephrin分子在多柔比星肾小球硬化大鼠模型中的表达．实用儿科临床杂志，2007, 22(17): 1299–1301.]
|
|
8 Wang LN, Yu L, Wen J, et al. Significance and expression of podocin in Adriamycin–induced nephritic rats. J Appl Clin Pediatr, 2008, 23(17): 1335–1338.[王丽娜，于力，温捷，等. podocin在多柔比星肾病大鼠模型中的表达及意义．实用儿科临床杂志，2008，23(17)：1335–1338.]
|
|
9 Boute N, Gribouval O, Roselli S, et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid–resistant nephrotic syndrome. Nat Genet, 2000, 24(4): 349–354.
|
|
10 Ruf RG, Lichtenberger A, Karle SM, et al. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol, 2004, 15(3): 722–732.
|
|
11 Mao J, Zhang Y, Du L, et al. Expression profile of nephrin, podocin, and CD2AP in Chinese children with MCNS and IgA nephropathy. Pediatr Nephrol, 2006, 21(11): 1666–1675.
|
|
12 Xing Y, Ding J, Fan QF, et al. Increased expression of podocyte molecules might cause proteinuria in adriamycin–induced nephrotic rats. Chin J Nephrol, 2006, 22(1): 27–32.[邢燕，丁洁，范青锋，等．足细胞分子高表达致阿霉素肾病大鼠发生蛋白尿. 中华肾脏病杂志，2006, 22(1): 27–32.]
|
|
13 Guan N, Ding J, Zhang JJ, et al. Relationship between expression of nephrin, podocin and α actinin with proteinuria in puromycin aminonucleoside nephrosis rats. Chin J Nephrol, 2004, 20(1): 26–32.[管娜，丁洁，张敬京，等．嘌呤霉素肾病大鼠肾小球中nephrin、podocin和α–actinin–4与蛋白尿的关系. 中华肾脏病杂志，2004, 20(1): 26–32.]
|
|
14 Makoto H, Kunimasa Y, Yukino N, et al. Nephrin and podocin expression around the onset of puromycin aminonucleoside nephrosis. J Pharmacol Sci, 2005, 97(2): 234–251.
|
|
15 Chen LP, Zhou QL, Ouyang C, et al. The protective effect of the combination of rosiglitazone and losartan on the podocytes of diabetic nephropathy rats. J Pract Med, 2007, 23(8): 1124–1126.[陈立平，周巧玲，欧阳春，等. 罗格列酮联合洛沙坦对糖尿病肾病大鼠足细胞的协同保护作用．实用医学杂志，2007, 23(8): 1124–1126.]
|
|
16 Farid N, Rawi R, Eliyahu K, et al. Glomerular abundance of nephrin and podocin in experimental nephritic syndrome: Different effects of antiproteinuric therapies. Am J Physiol Renal Physiol, 2005, 289(4): 880–890.
|
|
17 Zhou W, Chen N, Pan XX, et al. Glomerular expression of pododn in patients with nephrotic syndrome. Chin J Nephrol, 2005, 21(9): 502–505. [周伟，陈楠，潘晓霞，等．肾病综合征患者肾组织podocin的表达．中华肾脏病杂志，2005, 21(9): 502–505.]
|
|
18 Hiroshi K, Hiroko K, Hidetake K, et al. Cloning of rat homologue of podocin: Expression in proteinuric states and in developing glomeruli. J Am Soc Nephrol, 2003, 13(1): 46–56.
|